Genetics, autoantibodies and clinical features in understanding and predicting rheumatoid arthritis

Genetics, autoantibodies and clinical features in understanding and

predicting rheumatoid arthritis

Helm-van Mil, A.H.M. van der

Citation

Helm-van Mil, A. H. M. van der. (2006, October 26). Genetics, autoantibodies and clinical

features in understanding and predicting rheumatoid arthritis. Retrieved from

https://hdl.handle.net/1887/4929

Version:

Corrected Publisher’s Version

License:

Licence agreement concerning inclusion of doctoral thesis in the

_{Institutional Repository of the University of Leiden}

Downloaded from:

https://hdl.handle.net/1887/4929



#HA

P

TER¬

!"342!#4

/BJECTIVES¬ 4O¬ ASSESS¬ THE¬ ASSOCIATION¬ BETWEEN¬ THE¬ TUMOR¬ NECROSIS¬ FACTOR¬ RECEPTOR¬ ¬ 4.&2 ¬¬-2¬SINGLE¬NUCLEOTIDE¬POLYMORPHISM¬AND¬RHEUMATOID¬ARTHRITIS¬2! ¬SEVERITY¬ BY¬TAKING¬ADVANTAGE¬OF¬THE¬EXTREMES¬OF¬PHENOTYPES¬THAT¬EXIST¬IN¬ARTHRITIS¬ -ETHODS /UT¬OF¬THE¬,EIDEN¬%ARLY¬!RTHRITIS¬#OHORT¬¬PATIENTS ¬WE¬SELECTED¬PATIENTS THAT¬INITIALLY¬HAD¬THE¬DIAGNOSIS¬OF¬DEl¬NITE¬OR¬PROBABLE¬2!¬ACCORDING¬TO¬!#2¬CRITERIA¬AND DEVELOPED¬COMPLETE¬REMISSION¬¬PATIENTS ¬OR¬HAD¬THE¬WORST¬PROGRESSION¬TO¬DESTRUCTIVE DISEASE¬¬PATIENTS ¬!¬GROUP¬OF¬¬HEALTHY¬CONTROLS¬WAS¬INCLUDED¬)N¬THESE¬GROUPS¬THE 4.&2 GENOTYPE¬WAS¬DETERMINED

2ESULTS¬ 4HE¬ EXTREMES¬ OF¬ PHENOTYPES¬ DID¬ NOT¬ DIFFER¬ SIGNIl¬CANTLY¬ IN¬ GENOTYPE¬ DISTRIBU TION¬.O¬DIFFERENCE¬IN¬GENOTYPE¬DISTRIBUTION¬BETWEEN¬RHEUMATOID¬ARTHRITIS¬PATIENTS¬AND HEALTHY¬CONTROLS¬WAS¬OBSERVED¬

 #HA P TER¬ 'ENOTYPING¬OF¬4.&2¬¬-2¬POLYMORPHISM¬WAS¬PERFORMED¬BLINDED¬BY¬0#2 RESTRIC TION¬FRAGMENT¬POLYMORPHISM¬.A¬))) ¬AS¬PREVIOUSLY¬DESCRIBED¬ ¬4WO¬SAMPLES¬OF¬¬AND¬ ¬PATIENTS¬PROVIDES¬A¬POWER¬OF¬¬TO¬DETECT¬DIFFERENCES¬WITH¬¬CONl¬DENCE¬AND¬AN¬ ODDS¬RATIO¬OF¬¬BASED¬ON¬A¬2¬ALLELE¬FREQUENCY¬OF¬¬4HE¬8 _{TEST¬WAS¬USED¬TO¬COMPARE¬} THE¬GENOTYPE¬DISTRIBUTION¬BETWEEN¬THE¬TWO¬GROUPS¬OF¬2!¬PATIENTS¬!LL¬ALLELE¬AND¬GENOTYPE FREQUENCIES¬WERE¬IN¬(ARDY¬7EINBERG¬EQUILIBRIUM 2%35,43 4HE¬FREQUENCIES¬OF¬THE¬-¬AND¬2¬ALLELES¬AMONG¬THE¬¬2!¬PATIENTS¬WERE¬¬AND ¬RESPECTIVELY 4ABLE¬¬DEPICTS¬PATIENTS¬CHARACTERISTICS¬AND¬THE¬GENOTYPE¬DISTRIBUTIONS¬ OF¬ BOTH¬ GROUPS¬ OF¬ 2!¬ PATIENTS¬ AND¬ OF¬ THE¬ HEALTHY¬ CONTROLS¬ )N¬ THE¬ REMISSION¬ GROUP¬ ¬ PATIENTS¬ ¬HAD¬FULl¬LLED¬THE¬!#2 CRITERIA¬FOR¬DEl¬NITE¬2!¬AND¬¬PATIENTS¬ ¬THE¬ !#2¬ CRITERIA¬ FOR¬ PROBABLE¬ 2!¬ 4HE¬ EXTREMES¬ OF¬ PHENOTYPES¬ DID¬ NOT¬ DIFFER¬ SIGNIl¬CANTLY¬ IN¬ GENOTYPE¬ DISTRIBUTION¬ AS¬ WELL¬ AS¬ DETERMINED¬ IN¬ THE¬ TOTAL¬ GROUP¬ OF¬ PATIENTS¬ AS¬ WHEN ASSESSED¬IN¬THE¬l¬RST¬HALF¬OF¬PATIENTS¬AND¬REPLICATED¬IN¬THE¬SECOND¬HALF¬)N¬ADDITION¬THERE WAS¬ NO¬ SIGNIl¬CANT¬ DIFFERENCE¬ IN¬ (EALTH¬ !SSESSMENT¬ 1UESTIONNAIRE¬ AND¬ $ISEASE¬ !CTIVITY¬ 3CORE¬WHEN¬THE¬2¬AND¬-¬ALLELES¬WERE¬COMPARED¬DATA¬NOT¬SHOWN ¬.O¬DIFFERENCE¬ IN¬GENOTYPE¬DISTRIBUTION¬BETWEEN¬RHEUMATOID¬ARTHRITIS¬PATIENTS¬AND¬HEALTHY¬CONTROLS¬WAS

4ABLE¬¬#HARACTERISTICS¬OF¬AND 4.&2 ¬-2¬GENE¬POLYMORPHISM¬IN¬RHEUMATOID¬ARTHRITIS

 #HA P TER¬ 2%&%2%.#%3 ¬ ¬ "ARTON¬!¬*OHN¬3¬/LLIER¬7%2¬3ILMAN¬!¬7ORTHINGTON¬*¬!SSOCIATION¬BETWEEN¬RHEUMATOID ARTHRITIS¬AND¬POLYMORPHISM¬OF¬TUMOR¬NECROSIS¬FACTOR¬RECEPTOR¬))¬BUT¬NOT¬TUMOR¬NECROSIS¬ FACTOR¬RECEPTOR¬)¬IN¬CAUCASIANS¬!RTHRITIS¬2HEUM   ¬ ¬ $IEUDϬ0¬0ETIT¬%¬#AILLEAU -OINDRAULT¬3¬/SORIO¬*¬0IERLOT¬#¬-ARTINEZ¬-¬ET¬AL¬!SSOCIA TION¬BETWEEN¬TUMOR¬NECROSIS¬FACTOR¬RECEPTOR¬))¬AND¬FAMILIAL¬BUT¬NOT¬SPORADIC¬RHEUMATOID ARTHRITIS¬%VIDENCE¬FOR¬'ENETIC¬(ETEROGENITY¬!RTHRITIS¬2HEUM¬  ¬ ¬ 'LOSSOP¬ *2¬ .IXON¬ ."¬ $AWES¬ 04¬ (ASSELL¬ !"¬ -ATTEY¬ $,¬ .O¬ ASSOCIATION¬ OF¬ POLYMOR

PHISMS¬IN¬THE¬TUMOR¬NECROSIS¬FACTOR¬RECEPTOR¬)¬AND¬RECEPTOR¬))¬GENES¬WITH¬DISEASE¬SEVERITY¬ IN¬RHEUMATOID¬ARTHRITIS¬*¬2HEUMATOL¬  ¬ ¬ #ONSTANTIN¬!¬$IEUDE¬0¬,AUWERS #ANCES¬6¬*AMARD¬"¬-AZIERES¬"¬#AMBON 4HOMSON¬!¬ ET¬AL¬4UMOR¬NECROSIS¬FACTOR¬RECEPTOR¬¬GENE¬POLYMORPHISM¬AND¬SEVERITY¬OF¬RHEUMATOID¬ ARTHRITIS¬!RTHRITIS¬2HEUM¬¬  ¬ ¬ !KEN¬*¬"ILSEN¬*!-¬!LLAART¬#&¬(UIZINGA¬47*¬"REEDVELD¬&#¬4HE¬,EIDEN¬%ARLY¬!RTHRITIS #LINIC¬#LIN¬%XP¬2HEUM¬3UPPL¬ 3 3

¬ ¬ !L !NSARI¬ !3¬ /LLIER¬ 7%¬ 6ILLARREAL¬ *¬ /RDI¬ *¬ 4EH¬ ,3¬ (AJEER¬ !(¬ 4UMOR¬ NECROSIS¬ FACTOR¬ RECEPTOR¬))¬4.&2)) ¬EXON¬¬POLYMORPHISM¬IN¬SYSTEMIC¬LUPUS¬ERYTHEMATOSUS¬4ISSUE¬!N TIGENS¬ 

¬ ¬ +ALTENHËUSER¬3¬7AGNER¬5¬3CHUSTER¬%¬7ASSMUTH¬2¬3EIDEL¬7¬4RÚZLSCH¬-¬ET¬AL¬)MMUNO GENETIC¬MARKERS¬AND¬SEROPOSITIVITY¬PREDICT¬RADIOLOGICAL¬PROGRESSION¬IN¬EARLY¬RHEUMATOID ARTHRITIS¬INDEPENDENT¬OF¬DISEASE¬ACTIVITY¬*¬2HEUMATOL¬ 

¬ ¬ &ABRIS¬ -¬ 4OLUSSO¬ "¬ $I¬ 0OL¬ %¬ !SSALONI¬ 2¬ 3INIGAGLIA¬ ,¬ &ERRACCIOLI¬ '¬ 4UMOR¬ NECROSIS FACTOR ALPHA¬RECEPTOR¬TWO¬POLYMORPHISM¬IN¬PATIENTS¬FROM¬SOUTHERN¬%UROPE¬WITH¬MILD MODERATE¬AND¬SEVERE¬RHEUMATOID¬ARTHRITIS¬*¬2HEUMATOL¬ 

¬ ¬ $AHLQVIST¬32¬

EXON¬ ¬AND¬INTERLEUKIN ¬  ¬GENE¬POLYMORPHISMS¬ARE¬NOT¬ASSOCIATED¬WITH¬FAMILY HISTORY¬ BUT¬ TUMOR¬ NECROSIS¬ FACTOR¬ RECEPTOR¬ TYPE¬ ))¬ IS¬ ASSOCIATED¬ WITH¬ HYPERTENSION¬ IN¬ PATIENTS¬WITH¬RHEUMATOID¬ARTHRITIS¬IN¬PATIENTS¬FROM¬NORTHERN¬3WEDEN¬!RTHRITIS¬2HEUM